NeuroMetrix, Inc. (NASDAQ:NURO)
CAPS Rating:
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
This one is way oversold and due for some good news. IMO they look like they could be bought out with where the price is now. From my own dd I see their products as viable and legitimate. I look for the whole reimbursement problem to resolve itself. Like they say "Buy when there is blood on the streets". Now is the time to jump in on this one.